Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer (NSCLC)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer (NSCLC)

Published:2023-05-26 Issue:1 Volume:14 Page:517-525
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Assi Hazem I.¹²,Zerdan Maroun Bou¹²,Hodroj Mohammad¹,Khoury Makram³,Naji Nour Sabiha¹,Amhaz Ghid¹,Zeidane Reine Abou¹,El Karak Fadi³

Affiliation:

1. Department of Internal Medicine, Division of Hematology and Oncology, Naef K. Basile Cancer Institute, American University of Beirut Medical Center, Beirut, Lebanon

2. These authors contributed equally to this work

3. Department of Internal Medicine, Division of Hematology and Oncology, Hotel Dieu de France University Hospital, Beirut, Lebanon

Publisher

Impact Journals, LLC

Subject

Oncology

Reference36 articles.

1. Cancer statistics, 2014;Jemal;CA Cancer J Clin,2014

2. Effectiveness and safety of nivolumab in the treatment of lung cancer patients in France: preliminary results from the real-world EVIDENS study;Fayette;Oncoimmunology,2020

3. The biology and management of non-small cell lung cancer;Boshoff;Nature,2018

4. Lung cancer in never smokers--a different disease;Gazdar;Nat Rev Cancer,2007

5. Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing;Little;Science,2014

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reinitiating Chemotherapy beyond Progression after Maintenance Immunotherapy in Extensive-Stage Small-Cell Lung Cancer;Medicina;2024-07-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP